124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)-Reference-Cited by-同舟云学术

124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Published:2015-11-25 Issue:5 Volume:57 Page:701-707
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kist Jakob W.,de Keizer Bart,van der Vlies Manfred,Brouwers Adrienne H.,Huysmans Dyde A.,van der Zant Friso M.,Hermsen Rick,Stokkel Marcel P.M.,Hoekstra Otto S.,Vogel Wouter V.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference40 articles.

1. Current Thyroid Cancer Trends in the United States

2. Cancer Statistics, 2010

3. Recurrent Differentiated Thyroid Cancer

4. Guideline “differentiated thyroid carcinoma,” including diagnosis of thyroid nodules;Links;Ned Tijdschr Geneeskd.,2007

5. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer;Molecular Imaging and Biology;2024-08-22

2. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-12

3. Biomarkers and Molecular Imaging in Postoperative DTC Management;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023

4. Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer;Frontiers in Endocrinology;2022-09-08

5. Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer;Molecules;2022-08-03